We present the case of a 32-year-old woman who developed life-threatening catatonia in the setting of synthetic cannabis use. She was treated with high doses of lorazepam (up to 26 mg) and eventually transferred to receive electroconvulsive therapy (ECT). Synthetic cannabis poses a unique risk as it is widely available, difficult to regulate, and with adverse effects that are not well understood due to the presence of ever-changing chemical compounds. In this case report, we present one of the first cases of catatonia induced by first-time synthetic cannabinoids with no previous history of cannabis use disorder.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10906973 | PMC |
| http://dx.doi.org/10.7759/cureus.53324 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Molecular Positron Emission Tomography and Single-Photon Emission Computed Tomography Imaging for Understanding the Neurobiological Mechanisms of Electroconvulsive Therapy: A Scoping Review.
J ECT
December 2024
Department of Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, Leuven, Belgium.
Electroconvulsive therapy (ECT) effectively treats severe psychiatric disorders such as depression, mania, catatonia, and schizophrenia. Although its exact mechanism remains unclear, ECT is thought to induce neurochemical and neuroendocrine changes. Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) have provided vital insights into ECT's neurobiological effects.
View Article and Find Full Text PDFThe Use of Zolpidem in Catatonia: A Case Report.
Cureus
November 2024
Old Age Psychiatry, University Hospital Wishaw, Wishaw, GBR.
Catatonia is a complex neuropsychiatric syndrome characterised by abnormal psychomotor disturbance, which poses a diagnostic and treatment challenge to clinicians. It is a life-threatening condition in its severe form, termed malignant and characterised by hyperthermia and autonomic disturbances. Early recognition and treatment are important in its management.
View Article and Find Full Text PDFRecurrent Catatonia Following Radiation-Induced Hypothyroidism.
Prim Care Companion CNS Disord
November 2024
Department of Psychiatry, Rutgers New Jersey Medical School, Newark, New Jersey.
Delayed drug-induced catatonia in an adolescent girl-clinical implications: a case report.
J Med Case Rep
November 2024
Division of Child and adolescent psychiatry, Uppsala Academic Hospital, Uppsala, Sweden.
Article Synopsis
- Catatonia is a serious condition marked by psychiatric and motor issues, often linked with various mental illnesses, and may have a high mortality rate; its exact cause and classification remain debated among experts.
- A rare case involved a 17-year-old girl who developed catatonia after recreational drug use, with symptoms appearing a week later, and she had no prior mental health issues or substance abuse history.
- Treatment with lorazepam, memantine, and lithium successfully improved her condition, emphasizing the need for early recognition of psychomotor symptoms and suggesting that certain drugs may cause delayed onset catatonia, particularly in adolescents.
Autoimmune Thyroid Disease-Induced Catatonia With Normal Thyroid Function.
Prim Care Companion CNS Disord
October 2024
Department of Psychiatry, University of Nebraska Medical Center, Omaha, Nebraska.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!